The modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study
BACKGROUND AND AIM: Recent cross-sectional studies have been reported the possibility that light to moderate alcohol consumption might be negatively associated with fatty liver. However, there has been no large-scale longitudinal study addressing an impact of alcohol consumption on a development of fatty liver diagnosed by ultrasonography. Thus, we investigated the impact of alcohol consumption on a natural history of fatty liver.
METHODS: We analyzed 5437 apparently healthy Japanese who received the health checkup programs repeatedly over 10 years. In this study, we used a standardized questionnaire for addressing the medical history and lifestyle and used a standardized ultrasonographic diagnosis for fatty liver. The total amount of alcohol consumed per week was calculated and classified into four grades; none or minimal, light, moderate, or heavy alcohol consumption (< 40, 40-140, 140-280 or > 280 g/week, respectively). The hazard risks of alcohol consumption for the development of fatty liver were calculated by Cox hazard model after adjusting age, BMI, and parameters for lifestyle.
RESULTS: During 10 years of follow-up, fatty liver was continuously diagnosed just in 10% of men and 20% of women with fatty liver at the baseline. In men, the adjusted hazard risks of light and moderate alcohol consumption for the development of fatty liver were 0.72 (95% confidence interval 0.60-0.86, P < 0.001) and 0.69 (0.57-0.84, P < 0.001), respectively. However, they were not significant in women.
CONCLUSIONS: The newly onset of fatty liver was significantly repressed in apparently healthy men who consume light to moderate alcohol.
Additional Info
-
Authors
Hashimoto Y.; Hamaguchi M.; Kojima T.; Ohshima Y.; Ohbora A.; Kato T.; Nakamura N.; Fukui M. -
Issue
J Gastroenterol.Hepatol. / pages 546-552 / volume 30 -
Published Date
march 2015
Related items
- Global, regional, and national burden of liver cancer due to alcohol use, 1990-2021: results from the Global Burden of Disease study 2021
- Alcohol-Related Liver Disease, Followed by Metabolic Dysfunction-Associated Steatotic Liver Disease, Emerges as the Fastest-Growing Aetiologies for Primary Liver Cancer in the United States
- Global, regional, and national burdens of alcohol-related cirrhosis among women from 1992 to 2021 and its predictions
- Impact of binge drinking on alcoholic liver disease
- Prevalence, characteristics and outcomes of patients with metabolic and alcohol related/associated liver disease (MetALD): a systematic review and meta-analysis